X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse ALEMBIC LTD with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD vs TEVA PHARMA (Israel) - Comparison Results

ALEMBIC LTD    Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ALEMBIC LTD   TEVA PHARMA
EQUITY SHARE DATA
    ALEMBIC LTD
Mar-16
TEVA PHARMA
Dec-13
ALEMBIC LTD/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs532,677-   
Low Rs292,326-   
Sales per share (Unadj.) Rs4.71,536.5-  
Earnings per share (Unadj.) Rs8.896.0-  
Cash flow per share (Unadj.) Rs9.0220.2-  
Dividends per share (Unadj.) Rs0.1584.02-  
Dividend yield (eoy) %0.43.4 10.9%  
Book value per share (Unadj.) Rs27.71,706.7-  
Shares outstanding (eoy) m267.03848.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x8.71.6 534.2%   
Avg P/E ratio x4.726.1 18.0%  
P/CF ratio (eoy) x4.611.4 40.1%  
Price / Book Value ratio x1.51.5 101.0%  
Dividend payout %1.787.5 2.0%   
Avg Mkt Cap Rs m10,9622,121,238 0.5%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m2380-   
Avg. sales/employee Rs ThNM28,989.7-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM1,811.0-  
INCOME DATA
Net Sales Rs m1,2601,302,940 0.1%  
Other income Rs m2640-   
Total revenues Rs m1,5241,302,940 0.1%   
Gross profit Rs m83356,811 0.0%  
Depreciation Rs m61105,318 0.1%   
Interest Rs m025,592 0.0%   
Profit before tax Rs m285225,901 0.1%   
Minority Interest Rs m01,026 0.0%   
Prior Period Items Rs m2,0960-   
Extraordinary Inc (Exp) Rs m-32-148,292 0.0%   
Tax Rs m6-2,758 -0.2%   
Profit after tax Rs m2,34381,394 2.9%  
Gross profit margin %6.627.4 24.0%  
Effective tax rate %2.1-1.2 -175.4%   
Net profit margin %185.96.2 2,975.7%  
BALANCE SHEET DATA
Current assets Rs m1,689880,001 0.2%   
Current liabilities Rs m486767,435 0.1%   
Net working cap to sales %95.48.6 1,104.5%  
Current ratio x3.51.1 302.9%  
Inventory Days Days21791 238.9%  
Debtors Days Days8196 84.5%  
Net fixed assets Rs m1,624425,569 0.4%   
Share capital Rs m5343,207 16.7%   
"Free" reserves Rs m5,9600-   
Net worth Rs m7,4041,447,319 0.5%   
Long term debt Rs m104666,222 0.0%   
Total assets Rs m8,0102,977,635 0.3%  
Interest coverage x950.79.8 9,674.0%   
Debt to equity ratio x00.5 3.1%  
Sales to assets ratio x0.20.4 36.0%   
Return on assets %29.33.6 814.1%  
Return on equity %31.65.6 562.7%  
Return on capital %31.34.9 634.5%  
Exports to sales %2.90-   
Imports to sales %28.90-   
Net fx Rs m-3280-   
CASH FLOW
From Operations Rs m346207,621 0.2%  
From Investments Rs m-48-73,569 0.1%  
From Financial Activity Rs m-301-249,056 0.1%  
Net Cashflow Rs m-3-115,003 0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 64.14 Rs / USD

Compare ALEMBIC LTD With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare ALEMBIC LTD With: NOVARTIS  GSK PHARMA  STERLING BIOTECH  DR. DATSONS LABS  DISHMAN PHARMA  



Today's Market

Weak Finish to the Week Post Vishal Sikka's Exit as CEO of Infosys(Closing)

Share markets in India witnessed selling pressure, led by slump in shares of Infosys Ltd. after Vishal Sikka resigned as chief executive officer of the country's second-largest software services exporter.

Related Views On News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Sun Pharma: Price Erosion in US Impacts Growth (Quarterly Results Update - Detailed)

May 30, 2017

US markets decline while other geographies grow in the quarter.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC LTD SHARE PRICE


Aug 18, 2017 (Close)

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC LTD 5-YR ANALYSIS

COMPARE ALEMBIC LTD WITH

MARKET STATS